Header Logo

Connection

ADEL K EL-NAGGAR to Survival Analysis

Back to Details
This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Survival Analysis.
ADEL K EL-NAGGAR
Connection Strength
0.514
Survival Analysis
  1. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One. 2013; 8(6):e66778.
    View in: PubMed
    Score: 0.051
  2. Developmental transcription factor EN1--a novel biomarker in human salivary gland adenoid cystic carcinoma. Cancer. 2012 Mar 01; 118(5):1288-92.
    View in: PubMed
    Score: 0.044
  3. Meeting report--the NIDCR 2(nd) Salivary Gland Tumor Meeting, November 2008. Head Neck. 2009 Dec; 31(12):1542-3.
    View in: PubMed
    Score: 0.040
  4. Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients. Cancer. 2007 Nov 15; 110(10):2293-303.
    View in: PubMed
    Score: 0.034
  5. Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance. Am J Surg Pathol. 2004 Oct; 28(10):1299-310.
    View in: PubMed
    Score: 0.028
  6. Prognostic significance of DNA content in stage I adenocarcinoma of the lung. Int J Radiat Oncol Biol Phys. 1998 Jun 01; 41(3):573-8.
    View in: PubMed
    Score: 0.018
  7. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol. 2018 04; 79:1-8.
    View in: PubMed
    Score: 0.017
  8. Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma. Head Neck. 2017 12; 39(12):2433-2443.
    View in: PubMed
    Score: 0.017
  9. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck. 2016 12; 38(12):1739-1751.
    View in: PubMed
    Score: 0.016
  10. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):241-247.
    View in: PubMed
    Score: 0.015
  11. Phase II study of gefitinib in patients with advanced salivary gland cancers. Head Neck. 2015 May; 37(5):644-9.
    View in: PubMed
    Score: 0.014
  12. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors. Cytometry. 1995 Mar 01; 19(3):256-62.
    View in: PubMed
    Score: 0.014
  13. Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma. Head Neck. 2014 Aug; 36(8):1094-102.
    View in: PubMed
    Score: 0.013
  14. Primary sarcomas of the salivary glands: case series and literature review. Head Neck. 2013 Nov; 35(11):1551-7.
    View in: PubMed
    Score: 0.013
  15. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival. Head Neck. 2013 Oct; 35(10):1454-60.
    View in: PubMed
    Score: 0.012
  16. Minor salivary gland malignancies in the pediatric population. Head Neck. 2012 Nov; 34(11):1648-51.
    View in: PubMed
    Score: 0.011
  17. A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012 Mar 01; 18(5):1435-46.
    View in: PubMed
    Score: 0.011
  18. Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen. Cancer Immunol Immunother. 2012 Jun; 61(6):771-82.
    View in: PubMed
    Score: 0.011
  19. Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults. Head Neck. 2012 Sep; 34(9):1255-62.
    View in: PubMed
    Score: 0.011
  20. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma. Surgery. 1990 Dec; 108(6):981-5.
    View in: PubMed
    Score: 0.011
  21. Synovial sarcoma. A DNA flow cytometric study. Cancer. 1990 May 15; 65(10):2295-300.
    View in: PubMed
    Score: 0.010
  22. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer. 2007 Dec 15; 110(12):2726-31.
    View in: PubMed
    Score: 0.009
  23. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma. Cancer. 2005 Dec 25; 105(6):476-82.
    View in: PubMed
    Score: 0.008
  24. Akt activation correlates with adverse outcome in tongue cancer. Cancer. 2005 Dec 01; 104(11):2430-6.
    View in: PubMed
    Score: 0.008
  25. Presence of malignant tumor cells in persistent neck disease after radiotherapy for advanced squamous cell carcinoma of the oropharynx is associated with poor survival. Eur Arch Otorhinolaryngol. 2006 Apr; 263(4):313-8.
    View in: PubMed
    Score: 0.007
  26. Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication. Clin Cancer Res. 2004 Aug 15; 10(16):5554-7.
    View in: PubMed
    Score: 0.007
  27. Radiation therapy for early-stage carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys. 2004 Jul 01; 59(3):743-51.
    View in: PubMed
    Score: 0.007
  28. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med. 2004 Apr 01; 350(14):1405-13.
    View in: PubMed
    Score: 0.007
  29. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer. 2004 Mar 01; 100(5):900-5.
    View in: PubMed
    Score: 0.007
  30. Radiotherapy in the management of giant cell tumor of bone. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):158-65.
    View in: PubMed
    Score: 0.006
  31. Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck. Cancer. 2001 Nov 01; 92(9):2364-73.
    View in: PubMed
    Score: 0.006
  32. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene. 2000 May 11; 19(20):2398-403.
    View in: PubMed
    Score: 0.005
  33. High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc Natl Acad Sci U S A. 2000 Apr 11; 97(8):4174-9.
    View in: PubMed
    Score: 0.005
  34. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst. 1999 May 05; 91(9):763-71.
    View in: PubMed
    Score: 0.005
  35. Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma. Cancer. 1994 Nov 01; 74(9):2476-82.
    View in: PubMed
    Score: 0.003
  36. High correlation with survival of proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of the parotid gland. Otolaryngol Head Neck Surg. 1994 Oct; 111(4):460-6.
    View in: PubMed
    Score: 0.003
  37. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy. Cancer. 1994 Apr 01; 73(7):1895-903.
    View in: PubMed
    Score: 0.003
  38. Squamous carcinoma of oral tongue: prognostic significance of flow-cytometric DNA content. Mod Pathol. 1992 Mar; 5(2):141-5.
    View in: PubMed
    Score: 0.003
  39. Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy. Am J Clin Pathol. 1991 Jun; 95(6):844-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.